NRC Health(NRC) Price Forecast & Company Analysis. P/E · Dividend · Earnings · Price Target · RSI · MACD | US Stocks Today
September 11 at 7:30 PM ET (Korea 9/12 08:30)
Full metrics table
| Index | RUT | P/E | 85.02 | EPS (ttm) | 0.25 | Insider Own | 43.34% | Shs Outstand | 22.1M | Perf Week | -0.61% |
| Market Cap | 0.47B | Forward P/E | - | EPS next Y | - | Insider Trans | - | Shs Float | 12.5M | Perf Month | 2.47% |
| Enterprise Value | 0.55B | PEG | - | EPS next Q | 0.21 | Inst Own | 48.79% | Short Float | 5.08% | Perf Quarter | 12.4% |
| Income | 0.01B | P/S | 3.34 | EPS this Y | - | Inst Trans | -0.53% | Short Ratio | 5.48 | Perf Half Y | 28% |
| Sales | 0.14B | P/B | 71.4 | EPS next 5Y | -7.79% | ROA | 3.93% | Short Interest | 0.64M | Perf YTD | 12.52% |
| Book/sh | 0.3 | P/C | 140.29 | EPS past 3/5Y | -26.48% -19.02% | ROE | 39.17% | 52W High | -10.81% ($23.68) | Perf Year | 30.37% |
| Cash/sh | 0.15 | P/FCF | 21.59 | Sales past 3/5Y | -3.22% 0.61% | ROIC | 5.9% | 52W Low | 91.76% ($11.01) | Perf 3Y | -52.4% |
| Dividend Est. | $0.6 (2.84%) | EV/EBITDA | 23.7 | EPS Y/Y TTM | -67.39% | Gross Margin | 55.58% | Volatility(W/M) | 3.99% 4.31% | Perf 5Y | -55.93% |
| Dividend TTM | 0.6 | EV/Sales | 3.96 | Sales Y/Y TTM | -0.23% | Oper. Margin | 10.53% | ATR (14) | 0.92 | Perf 10Y | 40.19% |
| Dividend Ex-Date | 2026/9/25 | Quick Ratio | 0.65 | EPS Q/Q | -1686.9% | Profit Margin | 3.9% | RSI (14) | 49.53 | Recom | 1 |
| Dividend Gr. 3/5Y | -14.77% 19.88% | Current Ratio | 0.65 | Sales Q/Q | 3.98% | SMA20 | -1.64% ($21.47) | Beta | 0.27 | Target Price | $26 |
| Payout | 103.13% | Debt/Eq | 13.75 | Earnings | 2026/7/28 | SMA50 | -0.46% ($21.22) | Rel Volume | 0.81 | Prev Close | $21.26 |
| Employees | 357 | LT Debt/Eq | 13.13 | EPS/Sales Surpr. | 306.67% 1.41% | SMA200 | 13.23% ($18.65) | Avg Volume(3M) | 0.12M | Price | $21.12 |
| IPO | 2013/5/23 | Option/Short | Yes/Yes | Trades | 1475 | Volume | 94,306 | Change | -0.66% |
Company
NRC is a Healthcare sector company, analyzed across 14 metrics on this page including P/E, EPS, dividends, RSI, and MACD.
🏥 NRC Health is a U.S.-based healthcare information services company that measures and analyzes patient experience, reputation, and market insights for healthcare institutions. It provides subscription-based solutions that enable hospitals and health systems to collect patient feedback and apply it to operational improvements and reputation management, featuring a stable revenue structure built on recurring contracts.
Over the past 1 year, on the higher side
11% below its 1-year high.
Upcoming eventsNext ex-dividend (upcoming)
Ex-dividend September 25
NRC has weak earning power
10.53% of revenue is kept as operating profit.
Tap to view numbers
Growth has stalled
Earnings are expected to grow by -7.8% this year.
Tap to view numbers
The price looks about right
Trading at 85.0 times earnings.
Tap to view numbers
It has beaten expectations every time
Beat market estimates in the last 1 quarters.
Tap to view numbers
Opinions on the outlook are split
Analyst sentiment is Strong Buy.
Tap to view numbers
Holding long would have lost money
Would have changed by -52.4% if bought 5 years ago.
Tap to view numbers
Dividends are paid consistently
Pays 2.84% annually in dividends.
Tap to view numbers
Ownership looks stable
Institutions hold 48.8%.
Tap to view numbers
Multiple ETFs hold this stock
Buying this ETF gives you exposure to this stock as well.
RFDA 0.01%
DEEP 0.01%
ROSC 0.00%
DGRS 0.00%
AIMS 0.00%It ranks #4 in the industry
Based on market cap of $467M.
NRC $467M PER 85.0
VEEV $42B PER 43.2
BTSG $12B PER 43.9
TEM $11B PER -
FAQ
What kind of company is NRC?
NRC belongs to the Healthcare sector and operates in the Health Information Services industry.
What is the market cap of NRC?
The market cap of NRC is approximately $467M, ranking 3,279 within its sector.
Does NRC pay dividends?
NRC has a dividend yield of approximately 2.84%, with an annual dividend of $0.60.
What is the P/E ratio of NRC?
NRC has a P/E ratio of approximately 85.0x, which can be used to assess its valuation relative to the Healthcare sector average.
What is the 52-week high and low for NRC?
NRC has recorded a 52-week high of $23.68 and a low of $11.01.
